Minovivax (Minoxidil)

Minoxidil, the active ingredient in Minovivax, is a potassium channel opener presented as a topical solution for cutaneous use. It promotes hair growth and is indicated for treating androgenetic alopecia and other forms of hair loss in adults.

GNH USA supplies Minovivax as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable sourcing for healthcare providers.

Minovivax (minoxidil) is used to address hair loss conditions within the androgenetic alopecia pathway. - Androgenetic alopecia (male pattern): stimulates regrowth of thinning scalp hair. - Androgenetic alopecia (female pattern): increases hair density and thickness. - Non‑scarring hair loss: may support hair regrowth when applied as directed.

Minovivax may cause a range of cutaneous and systemic reactions, which are categorized by frequency and severity. Common Side Effects: - Scalp irritation: redness or burning sensation at the application site. - Itching: mild to moderate pruritus on the treated area. - Dryness or flaking: skin becomes dry or develops scales. - Unwanted facial hair growth: increased hair on cheeks or forehead.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Contact urticaria: hives developing after application. - Systemic hypotension: dizziness or fainting due to excessive absorption.

When using Minovivax, several precautions should be observed to ensure safety and optimal results. - Application area: apply only to a clean, dry scalp. - Avoid use on irritated, inflamed, or broken skin. - Do not combine with other topical scalp treatments without professional advice. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Hand hygiene: wash hands thoroughly after applying the product. - Store at room temperature below 25°C: keep in the original container, protect from light and moisture.

Minovivax can interact with certain medications and substances, requiring attention to avoid adverse effects. Major Interactions (Avoid): - Concurrent systemic vasodilators: may increase risk of hypotension. - Oral minoxidil therapy: additive blood pressure‑lowering effect. - Beta‑blockers: may blunt the vasodilatory response.

Moderate Interactions (Monitor Closely): - Alcohol consumption: can enhance skin irritation. - Topical corticosteroids: may alter drug absorption. - Other hair‑growth products: increased risk of scalp irritation.